Renal cell carcinoma (RCC) accounts for approximately 3% of all adult malignancies and is the most lethal genitourinary tumor. More than 40% of RCC patients die of the disease[@b1],[@b2]. Nephrectomy, either partial or radical, is the most effective treatment for this disease. Although laparoscopic or partial nephrectomy is widely used in early stage RCC, a large proportion of patients with RCC undergo open radical nephrectomy (RN). In recent years, only approximately 44.9% RN[@b3] have been performed with laparoscopy and 25.1%-32.2% RCC patients undergo partial nephrectomy (PN)[@b4],[@b5], according to data from Surveillance, Epidemiology, and End Results (SEER), Nationwide Inpatient Sample, and National Cancer Data Base. On reviewing the literature, we found morbidity of open RN ranged from 3.3% to 54%[@b6]--[@b16]. As a result of the lack of rigorous reporting using standardized methodologies, the reported complication rates vary widely between medical centers. This makes it difficult to assess surgical techniques and preoperative patient education.

In the past, several studies have tried to compare the complications of open transperitoneal and retroperitoneal RN[@b8],[@b9],[@b17],[@b18] but were limited by small sample size or nonstandardized reporting methods. Recently, researchers have compared complication rates between the two approaches in patients undergoing laparoscopic RN, although none used standardized reporting methodology. Thus, it remains unclear whether transperitoneal RN is associated with more complications than retroperitoneal RN.

Clavien defined a grading system for surgical complications in 1992[@b19] and renewed it in 2004[@b20]. In this five-tier system, complications are graded according to the severity of their impact and/or the intensity of the treatment required. Recently, 10 criteria have been proposed to standardize reporting in the surgical literature of the early complications of procedures[@b21]. In radical cystectomy patients, this standardized reporting methodology is used widely and accepted as an objective tool to characterize complications[@b22],[@b23]. Stephenson *et al.*[@b6] and Joudi *et al.*[@b8] used this methodology to report the complications of nephrectomy, with rates of 16% and 18.2%, respectively. In the present study, we aimed to report the clinicopathologic characteristics and early postoperative complications in a large contemporary RCC patient cohort. By comparing the complication rates between the transperitoneal RN and retroperitoneal RN groups using standardized reporting methodology, we aimed to determine the approach associated with more complications and the predictive factors for early postoperative complications.

Patients and Methods {#s2}
====================

Patients and surgical approach {#s2a}
------------------------------

Between 1996 and 2009, 1,068 RCC patients were treated surgically for RCC in our two centers. Prior patient consent and approval from the Institutional Research Ethics Committee were obtained for the use of these clinical materials for research purposes. We excluded 201 patients who received laparoscopic RN and 206 patients who received PN from the study. Overall, 103 patients whose records lacked sufficient follow-up data were excluded. The remaining 558 patients (424 from Sun Yat-sen University Cancer Center and 134 from the First Affiliated Hospital of Sun Yat-sen University) who underwent RN were enrolled in this study. A total of 347 patients (62.2%) underwent transperitoneal RN and 211 (37.8%) underwent retroperitoneal RN. Transperitoneal RN and retroperitoneal RN were performed as described by Hinman[@b24]. The decision to use a retroperitoneal or transperitoneal approach was influenced predominantly by clinical TNM stage. In general, we chose transperitoneal RN for large tumors with local progression. For localized tumors, either transperitoneal RN or retroperitoneal RN was the preferred option, according to the surgeon\'s discretion.

Defining and grading complications {#s2b}
----------------------------------

We retrospectively reviewed hospitalization information obtained from our renal tumor database. After reviewing the charts, outpatient notes, and correspondence with local physicians, we retrospectively recorded the complication rate. Early complications were defined as any deviation from the normal postoperative course occurring within 90 days after surgery, and graded according to the five-tier modified Clavien system[@b6]. Martin *et al.*\'s 10 criteria for accurate and comprehensive reporting of surgical complications[@b21] were applied. Complications were categorized principally according to the organ and/or system involved. Ileus was defined as nil by mouth status maintained beyond postoperative day 5 or the postoperative placement of a nasogastric tube. Acute renal failure was defined as an elevation in serum creatinine greater than 50% from baseline or hemodialysis requirement. A postoperative hemorrhagic episode was defined as any postoperative acute bleeding that resulted in a decrease in serum hemoglobin below 80 g/L, hemodynamic instability, or reoperation. Chylous ascites was suspected when there was increased drain output of milky-colored fluid after the start of oral intake food and was confirmed by analysis of ascitic fluid obtained from the drain. Other specific conditions were verified based on routine diagnostic studies.

Statistical analysis {#s2c}
--------------------

Continuous variables were compared using Student\'s *t* test for normally distributed data and the Mann-Whitney *U* test for non-normally distributed data. Categorical variables were compared using the chi-square and Fisher\'s exact tests. Logistic regression analysis was used to identify variables that were associated with complications using a stepwise forward selection procedure. All statistical analyses were conducted using the SPSS v.13.0 statistical software package (SPSS, Chicago, IL, USA). In all cases, *P* \< 0.05 was considered statistically significant.

Results {#s3}
=======

Patient information and clinicopathologic features {#s3a}
--------------------------------------------------

A total of 360 male and 198 female RCC patients were included in this study, with a median age of 52 years (range, 4-83 years). Median follow-up was 45 months (range, 3-147 months). The patients\' clinicopathologic parameters are listed in [**Table 1**](#cjc-32-08-461-t01){ref-type="table"}.

Transperitoneal RN was used more often in RCC patients with high American Society of Anesthesiologists scores (*P* = 0.001), larger tumors (*P* \< 0.001), higher T categroy (*P* \< 0.001), higher N categroy (*P* \< 0.001), higher M categroy (*P* = 0.001), and lower body-mass index (*P* = 0.008). However, transperitoneal RN was associated with higher volumes of estimated blood loss (*P* = 0.001). Other clinicopathologic parameters, including age, sex, operative time, length of hospital stay, and transfusion rate, were not significantly different between the two groups.

###### Clinical features, intraoperative data, and hospitalization duration of 568 patients with renal cell cancer

  Characteristic                                                     Total          TPRN (n = 347)    RTPRN (n = 211)      *P*
  ------------------------------------------------------------ ------------------ ------------------ ------------------ ---------
  Median age (years, range)                                        52 (4-83)          53 (4-83)          52 (12-79)       0.476
  Male patients (n, %)                                             360 (64.5)         220 (63.4)         140 (66.4)       0.523
  Left-sided tumors (n, %)                                         281 (50.4)         176 (50.7)         105 (49.8)       0.914
  ASA score (n, %)                                                                                                        0.001
   1                                                               243 (43.5)         150 (43.2)         93 (44.1)      
   2                                                               137 (24.6)         69 (19.9)          68 (32.2)      
   3                                                               146 (26.2)         103 (29.7)         43 (20.4)      
   4                                                                32 (5.7)           25 (7.2)           7 (3.3)       
  Patients with prior abdominal surgery (n, %)                      41 (7.3)           26 (7.5)           15 (7.1)        1.000
  Mean body-mass index (kg/m^2^, range)                         23.3 (14.0-39.0)   23.0 (14.0-39.0)   23.9 (16.9-36.2)    0.008
  Overweight (body-mass index \>25 kg/m^2^) (n, %)                 168 (30.1)         92 (26.5)          76 (36.0)        0.022
  Median tumor size (cm, interquartile range)                    5.5 (4.0-8.0)      6.0 (5.0-9.0)      4.9 (3.0-6.0)     \<0.001
  T category (n, %)                                                                                                      \<0.001
   T1a                                                             151 (27.1)         62 (17.9)          89 (42.2)      
   T1b                                                             198 (35.5)         113 (32.6)         85 (40.3)      
   T2                                                              125 (22.4)         96 (27.7)          29 (13.7)      
   T3-T4                                                           84 (15.1)          76 (21.9)           8 (3.8)       
  N category (n, %)                                                                                                      \<0.001
   N0                                                              329 (59.0)         234 (67.4)         95 (45.0)      
   N1+2                                                             53 (9.5)          43 (12.4)           10 (4.7)      
   Nx                                                              176 (31.5)         70 (20.2)          106 (50.2)     
  M category (n, %)                                                                                                       0.001
   M0                                                              504 (90.3)         302 (87.0)         202 (95.7)     
   M1                                                              54 (10.4)          45 (13.0)           9 (4.3)       
  Median operative time (min, interquartile range)               155 (120-185)      155 (121-189)      150 (120-185)      0.915
  Median length of hospital stay (days, interquartile range)        9 (7-11)           9 (7-12)           9 (8-11)        0.910
  Reoperation (n, %)                                                6 (1.1)            4 (1.2)            2 (0.9)         1.000
  Complication-related deaths (n, %)                                1 (0.2)            1 (0.3)             0 (0)          1.000
  Median estimated blood loss (mL, interquartile range)          150 (100-300)      200 (100-350)      150 (100-200)      0.001
  Transfusion required (n, %)                                       40 (7.2)           28 (8.1)           12 (5.7)        0.315

TPRN, transperitoneal radical nephrectomy; RTPRN, retroperitoneal radical nephrectomy; ASA, American Society of Anesthesiologists.

Complications {#s3b}
-------------

The details of complications are listed in [**Table 2**](#cjc-32-08-461-t02){ref-type="table"}. Of the 558 patients, 105 (18.8%) had one or more postoperative complications. Thirty-eight patients had multiple adverse events (101 complications) and 67 patients had a single adverse event (67 complications), resulting in a total of 168 postoperative complications. The overall rates of grades I to V complications were 5.6%, 10.8%, 2.2%, 0.4%, and 0.2%, respectively.

In the transperitoneal RN group, the complication rate was 19.0% (66/347), of which 4.6% were grade I, 11.8% were grade II, 2.0% were grade III, 0.3% were grade IV, and 0.3% were grade V. In the retroperitoneal RN group, the complication rate was 18.5% (39/211); the overall rates of grades I to V complications were 7.1%, 9.0%, 1.9%, 0.5%, and 0, respectively. Patients who underwent transperitoneal RN did not experience more complications than those who underwent retroperitoneal RN (*P* = 0.911). On subgroup analysis, neither grade I/II nor grades III-V complications showed any significant differences between the transperitoneal RN and retroperitoneal RN groups.

There were 41 procedure-related complications in 32 patients ([**Table 3**](#cjc-32-08-461-t03){ref-type="table"}). The procedure-related complication rate did not differ significantly between the transperitoneal RN and retroperitoneal RN groups (6.1% vs. 5.2%, *P* = 0.851). No grade V procedure-related complications occurred. Ileus and chylous ascites occurred in 2.3% and 1.4% of patients who underwent transperitoneal RN, respectively; no cases of ileus or chylous ascites occured in those who underwent retroperitoneal RN.

One patient died of congestive heart failure, and 6 patients needed reoperations for severe complications. The most common complication categories were gastrointestinal (23.8%), bleeding (15.5%), pulmonary (13.7%), genitourinary (11.3%), cardiac (10.7%), and infectious (10.7%). [**Table 2**](#cjc-32-08-461-t02){ref-type="table"} shows the frequency of individual complications within each category.

Predictors of postoperative complications {#s3c}
-----------------------------------------

Univariate analysis showed age (*P* = 0.008), American Society of Anesthesiologists score (*P* = 0.013), operative time (*P* = 0.012), and estimated blood loss (*P* = 0.001) to be significant in predicting the occurrence of a complication. On multivariate analysis for any grade of complication, age (*P* = 0.016) and estimated blood loss (*P* = 0.001) were significant predictors ([**Table 4**](#cjc-32-08-461-t04){ref-type="table"}).

Stage (*P* = 0.013), operative time (*P* = 0.007), and estimated blood loss (*P* \< 0.001) were associated with procedure-related complications on univariate analysis. However, multivariate analysis revealed that estimated blood loss (*P* \< 0.001) is the sole independent predictor for procedure-related complications ([**Table 4**](#cjc-32-08-461-t04){ref-type="table"}).

###### Overall postoperative complication data of 568 patients with renal cell cancer

  Complication                                          Total      TPRN (n = 347)   RTPRN (n = 211)    *P*
  -------------------------------------------------- ------------ ---------------- ----------------- -------
  Patients with complications (n, %)                  105 (18.8)     66 (19.0)         39 (18.5)      0.911
  Total number of complications                          168            108               60          0.568
  Grade I/II complications (n, %)                     91 (16.3)      57 (16.4)         34 (16.1)      1.000
   Grade I                                             31 (5.6)       16 (4.6)         15 (7.1)      
   Grade II                                           60 (10.8)      41 (11.8)         19 (9.0)      
  Grades III-V complications (n, %)                    14 (2.5)       9 (2.6)           5 (2.4)       1.000
   Grade III                                           11 (2.2)       7 (2.0)           4 (1.9)      
   Grade IV                                            2 (0.4)        1 (0.3)           1 (0.5)      
   Grade V                                             1 (0.2)        1 (0.3)              0         
  Gastrointestinal (23.8%, n = 40)                        40             27               13          0.504
   Ileus                                                  8              8                 0         
   SBO                                                    1              1                 0         
   Diarrhea                                               9              5                 4         
   Fistula, intestinal                                    2              1                 1         
   Constipation                                           5              2                 3         
   Emesis                                                 7              4                 3         
   Colitis                                                3              1                 2         
   Chylous ascites                                        5              5                 0         
  Infectious (10.7%, n = 18)                              18             15                3          0.082
   Fever                                                  15             14                1         
   Sepsis                                                 1              0                 1         
   Cholecystitis                                          2              1                 1         
  Wound (3.6%, n = 6)                                     6              4                 2          0.312
   Seroma                                                 6              4                 2         
  Genitourinary (11.3%, n = 19)                           19             9                10          0.228
   Renal failure                                          16             9                 7         
   Urinary retention                                      3              0                 3         
  Cardiac (10.7%, n = 18)                                 18             11                7          1.000
   Arrhythmia                                             8              5                 3         
   Hypotension                                            6              2                 4         
   Congestive heart failure                               3              3                 0         
   Angina                                                 1              1                 0         
  Pulmonary (13.7%, n = 23)                               23             12               11          0.380
   Atelectasis                                            1              1                 0         
   Pneumonia                                              7              3                 4         
   Respiratory distress                                   3              2                 1         
   Pneumothorax                                           4              2                 2         
   Pleural effusion                                       8              4                 4         
  Bleeding (15.5%, n = 26)                                26             19                7          0.302
   Postoperative bleed other than gastrointestinal        6              4                 2         
   Anemia requiring transfusion                           20             15                5         
  Thromboembolic (5.4%, n = 9)                            9              8                 1          0.164
   Deep venous thrombosis                                 1              1                 0         
   Pulmonary embolus                                      1              1                 0         
   Superficial phlebitis                                  1              1                 0         
   Thrombocytopenia                                       6              5                 1         
  Neurological (2.4%, n = 4)                              4              2                 2          0.635
   Vertigo                                                1              0                 1         
   Loss of consciousness                                  1              1                 0         
   Seizure                                                2              1                 1         
  Others (3.0%, n = 5)                                    5              1                 4          0.070
   Acidosis                                               1              0                 1         
   Rash                                                   4              1                 3         

TPRN, transperitoneal radical nephrectomy; RTPRN, retroperitoneal radical nephrectomy; ASA, American Society of Anesthesiologists.

###### Procedure-related complications in patients treated with TPRN and RTPRN

  Complication                    Total      Grade                       
  ----------------------------- ---------- --------- --------- --------- ---------
  TPRN (n, %)                    21 (6.1)   6 (1.7)   9 (2.6)   5 (1.4)   1 (0.3)
   Retroperitoneal hemorrhage       4          0         0         3         1
   Fistula, intestinal              1          0         0         1         0
   Bowel obstruction                8          0         8         0         0
   Acute renal failure              9          8         0         1         0
   Chylous ascites                  5          0         4         1         0
   Pneumothorax                     2          0         0         2         0
   Total                            29         8        12         8         1
  RTPRN (n, %)                   11 (5.2)   7 (3.3)   1 (0.5)   2 (0.9)   1 (0.5)
   Retroperitoneal hemorrhage       2          0         1         1         0
   Fistula, intestinal              1          0         0         0         1
   Acute renal failure              7          7         0         0         0
   Pneumothorax                     2          1         0         1         0
   Total                            12         8         1         2         1

TPRN, transperitoneal radical nephrectomy; RTPRN, retroperitoneal radical nephrectomy. All values are presented as the number of patients.

###### Logistic regression analysis of variables associated with early complications

  Variable                             Univariate analysis   Multivariate                                
  ----------------------------------- --------------------- -------------- ------- ------- ------------- -------
  Early postoperative complications                                                                      
   Age                                        1.023          1.006-1.040    0.008   1.021   1.004-1.038   0.016
   Sex                                        1.250          0.794-1.969    0.336   1.064   0.664-1.705   0.797
   ASA score                                  1.316          1.060-1.633    0.013   1.129   0.853-1.494   0.396
   Body-mass index                            1.045          0.986-1.108    0.138   1.038   0.976-1.104   0.241
   Prior abdominal surgery                    0.579          0.222-1.513    0.265   0.495   0.182-1.350   0.170
   Tumor size                                 1.004          0.998-1.010    0.204   1.002   0.994-1.010   0.650
   Tumor side                                 1.000          0.728-1.374    0.999   1.003   0.723-1.392   0.985
   Stage                                      1.131          0.931-1.375    0.215   0.943   0.721-1.235   0.671
   Operative time                             1.004          1.001-1.008    0.012   1.002   0.998-1.006   0.411
   Estimated blood loss                       1.001          1.000-1.001    0.001   1.001   1.000-1.001   0.001
   Surgical approach                          1.036          0.668-1.607    0.875   0.904   0.556-1.470   0.685
  Procedure-related complications                                                                        
   Age                                        1.011          0.984-1.038    0.443   1.007   0.974-1.041   0.686
   Sex                                        1.053          0.497-2.232    0.893   0.807   0.367-1.774   0.594
   ASA score                                  1.311          0.917-1.876    0.138   1.110   0.691-1.783   0.666
   Body-mass index                            1.011          0.916-1.116    0.823   1.020   0.922-1.128   0.706
   Prior abdominal surgery                    0.392          0.052-2.946    0.363   0.376   0.048-2.925   0.350
   Tumor size                                 1.003          0.992-1.014    0.584   0.991   0.977-1.005   0.198
   Tumor side                                 0.593          0.284-1.236    0.163   0.583   0.270-1.260   0.170
   Stage                                      1.464          1.083-1.979    0.013   1.351   0.905-2.016   0.141
   Operative time                             1.007          1.002-1.013    0.007   1.002   0.995-1.008   0.628
   Estimated blood loss                       1.001          1.000-1.001    0.001   1.001   1.000-1.001   0.001
   Surgical approach                          1.171          0.553-2.481    0.680   0.850   0.364-1.985   0.707

ASA, American Society of Anesthesiologists; BMI, body-mass index; OR, odds ratio; CI, confidence interval.

Discussion {#s4}
==========

The complication of open RN could be perceived as outdated due to the rise in popularity of laparoscopic RN or PN for early-stage RCC. Several large-scale studies with long-term follow-up durations have confirmed that laparoscopic RN[@b11],[@b25] or PN[@b26]--[@b28] can achieve similar oncological outcomes to open RN in the treatment of localized RCC. However, even in the USA, less than half of the RNs were performed by laparoscopy[@b3],[@b29], and only 32.2% of patients with stage I RCC underwent PN in recent years[@b4]. Under the present conditions, a large portion of patients with RCC still undergo open RN. Furthermore, there is a lack of rigorous reporting to compare the complication rate between transperitoneal and retroperitoneal open RN using standardized methodology. Hence, our study has important clinical significance.

The reporting of complications after surgery is often confusing, making it difficult to compare complications between different centers and evaluate patient counseling. To solve this problem, Martin *et al.*[@b21] proposed 10 criteria for reporting early postoperative complications. Detailed reporting is suggested[@b21], but even with these criteria, two issues continue to puzzle surgeons. The first is that there is no consensus on how to define a complication; in other words, opinions vary on which types of event should be considered complications. This disagreement has led to extreme variations in the reported incidences of complications. [**Table 5**](#cjc-32-08-461-t05){ref-type="table"} lists some examples. The reported incidence of complications of RN ranges from 3.3% to 54.0%. Complications should be defined as any deviation from the normal postoperative course, which means that asymptomatic complications such as arrhythmia and atelectasis should also be taken into account[@b20]. According to this principle, complications should be listed in detail and classified by system. The second problem is that we also lack the conventional use of a standard grading system to stratify complications by severity. On reviewing urological literature focused on complications, we found that few studies graded complications[@b6],[@b8]. Some researchers use "major" or "minor" to stratify the severity of complications, but there is no unambiguous definition of these terms. In 1992, Clavien *et al.*[@b19] defined a system to grade surgical complications, classifying them into five grades according to their severity. The system was later modified and simplified for convenience[@b20]. This grading system has been widely accepted for reporting the severity of complications[@b8],[@b22],[@b23]. Stephenson *et al.*[@b6] reported complications in a group of 688 patients who underwent open RN. In that study, 16% experienced a postoperative complication, and only 2.5% experienced grades III to V complications; the perioperative mortality rate was 0.4%, and only a few patients (0.6%) required re-exploration. In the present study, we used the same standard method to categorize and grade complications. We report a complication rate of 18.8% for the whole group and a rate of 2.5% for grades III to V complications. The mortality rate was 0.2%, and the reoperation rate was 1.1%. Using this standard method, complication rates were found to be comparable between different medical centers. Our study also confirmed that RN is a safe procedure that is associated with low rates of serious morbidity and mortality.

###### Reported incidence of postoperative complications of radical nephrectomy

  Investigator                  Country     Year      Number of patients   Laparoscopic   Complication rate   TPRN    RTPRN   Standard system
  ---------------------------- --------- ----------- -------------------- -------------- ------------------- ------- ------- -----------------
  Shekarriz *et al*. [@b7]        USA     1991-1997           60                No              3.3%           NA      NA           No
  Shuford *et al*. [@b9]          USA     1999-2001           41                No              10.0%          NA      NA           No
  Mejean *et al*. [@b10]        France    1986-1997          656                No              20.9%          NA      NA           No
  Dunn *et al*. [@b11]           Egypt    1990-1999           33                No              54.0%          NA      NA           No
  Hemal *et al*. [@b12]          India    1998-2006           71                No              15.5%          NA      NA           No
  Gill *et al*. [@b13]            USA     1997-2000           34                No              24.0%          NA      NA           No
  Herranz Amo *et al*.[@b14]    Spanish      NA              109                No              24.8%          NA      NA           No
  Stephenson *et al*.[@b6]        USA     1995-2002          688                No              16.0%          NA      NA           Yes
  Joudi *et al*. [@b8]            USA     2000-2003         18575               No              18.2%          NA      NA           Yes
  Desai *et al*. [@b32]           USA     1999-2001          102               Yes              16.7%         20.0%   13.5%         No
  Taue *et al*. [@b15]           Japan       NA              100               Yes              9.0%          4.5%    9.1%          No
  Berdjis *et al*. [@b16]       Germany   1999-2003           63               Yes              9.5%          11.8%   7.0%          No
  Zhang *et al*.                 China    1999-2009          558                No              18.8%         19.0%   18.5%         Yes

TPRN, transperitoneal radical nephrectomy; RTPRN, retroperitoneal radical nephrectomy; NA, not available.

Whether RN should be performed using transperitoneal or retroperitoneal approach remains controversial. Proponents for the transperitoneal approach claim that this approach provides a great space in which to work, especially when the tumor is very large or there is accidental bleeding. However, advocates for the retroperitoneal approach can also use this argument. They believe that the retroperitoneal approach provides quicker access to the renal hilum without the need for mobilization and retraction of the bowel[@b30]. Moreover, in obese patients, the panniculus falls forward. Retroperitoneal incision is not straightforward and is easy to perform. Although two prospective randomized studies[@b31],[@b32] have suggested that the transperitoneal approach does not lead to more complications than the retroperitoneal approach in RN for RCC, this conclusion has not been confirmed by rigorous reporting using standardized methodology. In our present study, we compared early postoperative complications between transperitoneal RN and retroperitoneal RN for RCC, using standardized reporting methodology, and found that the complication rate between transperitoneal RN and retroperitoneal RN group was similar (19.0% vs. 18.5%, *P* = 0.911). Our result confirmed the above-mentioned conclusion.

We also found that transperitoneal RN was used more often in RCC patients with high ASA scores, larger tumors, and higher stage disease. However, patients in the transperitoneal RN group did not show a significantly higher incidence of complications than those in the retroperitoneal RN group, although the estimated blood loss was greater in the transperitoneal RN group. It should be noted that certain complications, including bowel obstruction and chylous ascites, only occurred in the transperitoneal RN group. The careful mobilization and retraction of bowel with the ligation of every suspicious lymphatic vessel may help to reduce this kind of complication.

Patient age and estimated blood loss were significant predictors of postoperative complications on multivariate analysis. The approach (transperitoneal vs. retroperitoneal) did not influence the rate of postoperative complications. Thus, regardless of which surgical approach is chosen, reducing bleeding is the key to reducing the complication rate, especially in elderly patients.

The limitations of this study include the fact that it is a retrospective study, and thus some bias is inevitable. Another limitation is the relative small number of cases in the retroperitoneal RN group. Verification of the results using a larger cohort is needed.

Conclusions {#s5}
===========

Open RN is a safe procedure that is associated with low rates of serious morbidity and mortality. Using a standardized reporting methodology, we found the complications in this cohort were comparable with previous reports. Compared with retroperitoneal RN, transperitoneal RN was not associated with more complications. Older patient age and more blood loss at surgery were independent predictors for higher early postoperative complication rates.
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